Compound class:
Synthetic organic
Comment: HS-173 (as compound 19c) is reported as a selective inhibitor of phosphatidylinositol 3-kinase (PI3K) α [1].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Kim O, Jeong Y, Lee H, Hong SS, Hong S. (2011)
Design and synthesis of imidazopyridine analogues as inhibitors of phosphoinositide 3-kinase signaling and angiogenesis. J Med Chem, 54 (7): 2455-66. [PMID:21388141] |
2. Lee H, Jung KH, Jeong Y, Hong S, Hong SS. (2013)
HS-173, a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis. Cancer Lett, 328 (1): 152-9. [PMID:22929971] |
3. Son MK, Ryu YL, Jung KH, Lee H, Lee HS, Yan HH, Park HJ, Ryu JK, Suh JK, Hong S et al.. (2013)
HS-173, a novel PI3K inhibitor, attenuates the activation of hepatic stellate cells in liver fibrosis. Sci Rep, 3: 3470. [PMID:24326778] |